NEUROPACE, INC. Deferred Revenue Recognized
NEUROPACE, INC. (NPCE) reported Deferred Revenue Recognized of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-11
- NEUROPACE, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $100.00K, a 50.00% decline year-over-year.
- NEUROPACE, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $400.00K, a 100.00% increase year-over-year.
- NEUROPACE, INC. contract with customer, liability, revenue recognized for fiscal 2025 was $600.00K.
- NEUROPACE, INC. contract with customer, liability, revenue recognized for fiscal 2023 was $1.10M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | $100.00K 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | $600.00K 10-K · filed 2026-03-03 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | $600.00K 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-11 | $600.00K 10-Q · filed 2026-08-11 | ||
| 2025-03-31 | $200.00K 10-Q · filed 2026-05-12 | |||
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-04 | $900.00K 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-12 | $700.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $600.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $1.10M 10-K · filed 2025-03-04 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |